Thomas J. Stopka

4.3k total citations · 1 hit paper
120 papers, 2.6k citations indexed

About

Thomas J. Stopka is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Thomas J. Stopka has authored 120 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Epidemiology, 74 papers in Public Health, Environmental and Occupational Health and 24 papers in Infectious Diseases. Recurrent topics in Thomas J. Stopka's work include Opioid Use Disorder Treatment (68 papers), HIV, Drug Use, Sexual Risk (67 papers) and Substance Abuse Treatment and Outcomes (40 papers). Thomas J. Stopka is often cited by papers focused on Opioid Use Disorder Treatment (68 papers), HIV, Drug Use, Sexual Risk (67 papers) and Substance Abuse Treatment and Outcomes (40 papers). Thomas J. Stopka collaborates with scholars based in United States, Germany and United Kingdom. Thomas J. Stopka's co-authors include Marc R. Larochelle, Alexander Y. Walley, Dana Bernson, Thomas Land, Jane M. Liebschutz, Ziming Xuan, Sarah M. Bagley, Na Wang, Kenneth Chui and Alysse G. Wurcel and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Thomas J. Stopka

110 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality

2018 740 citations Marc R. Larochelle, Dana Bernson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas J. Stopka United States	23	1.7k	1.7k	474	414	402	120	2.6k
Barrot H. Lambdin United States	26	953 0.6×	1.3k 0.8×	773 1.6×	615 1.5×	359 0.9×	93	2.1k
Bohdan Nosyk Canada	35	2.0k 1.2×	2.8k 1.6×	1.4k 3.0×	607 1.5×	639 1.6×	186	4.4k
April M. Young United States	25	997 0.6×	1.3k 0.7×	427 0.9×	465 1.1×	316 0.8×	125	2.2k
Nickolas Zaller United States	36	1.8k 1.0×	2.3k 1.4×	1.1k 2.3×	895 2.2×	640 1.6×	153	4.1k
Leo Beletsky United States	35	2.9k 1.7×	2.9k 1.7×	604 1.3×	737 1.8×	567 1.4×	166	4.6k
Joshua A. Barocas United States	22	868 0.5×	951 0.6×	238 0.5×	207 0.5×	294 0.7×	99	1.6k
Paula J. Lum United States	29	879 0.5×	2.3k 1.4×	1.1k 2.2×	484 1.2×	238 0.6×	77	3.0k
Noa Krawczyk United States	30	1.9k 1.1×	1.6k 0.9×	120 0.3×	366 0.9×	606 1.5×	115	2.6k
Jeffrey Bratberg United States	22	1.0k 0.6×	700 0.4×	142 0.3×	219 0.5×	164 0.4×	97	1.5k
Suzan M. Walters United States	22	589 0.3×	997 0.6×	471 1.0×	347 0.8×	108 0.3×	60	1.4k

Countries citing papers authored by Thomas J. Stopka

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Stopka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Stopka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Stopka more than expected).

Fields of papers citing papers by Thomas J. Stopka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Stopka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Stopka. The network helps show where Thomas J. Stopka may publish in the future.

Co-authorship network of co-authors of Thomas J. Stopka

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Stopka. A scholar is included among the top collaborators of Thomas J. Stopka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Stopka. Thomas J. Stopka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morenz, Anna M., Robin M. Nance, Judith Feinberg, et al.. (2025). Barriers to accessing medications for opioid use disorder among rural individuals. International Journal of Drug Policy. 140. 104805–104805. 4 indexed citations

Hughto, Jaclyn M. W., Patricia Case, Wilson R. Palacios, et al.. (2024). Views and experiences of involuntary civil commitment of people who use drugs in Massachusetts (Section 35). Drug and Alcohol Dependence. 263. 112391–112391. 3 indexed citations

Tully, Damien C., Karen A. Power, Thomas J. Stopka, et al.. (2024). Validation of dried blood spots for capturing hepatitis C virus diversity for genomic surveillance. Journal of Viral Hepatitis. 31(5). 266–270. 1 indexed citations

Walters, Suzan M., Robin Baker, David Frank, et al.. (2024). Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative. Harm Reduction Journal. 21(1). 154–154. 3 indexed citations

Bauer, Cici, Jack Cordes, Dana Bernson, et al.. (2024). Trends in Fatal Opioid-Related Overdose in American Indian and Alaska Native Communities, 1999–2021. American Journal of Preventive Medicine. 66(6). 927–935. 3 indexed citations

Dowd, Patrick F., et al.. (2024). Syringe Access, Syringe Sharing, and Perceptions of HCV: A Qualitative Study Exploring the HCV Risk Environment in Rural Northern New England, United States. Viruses. 16(9). 1364–1364. 2 indexed citations

Stopka, Thomas J., et al.. (2024). More than Just Buying a Van: Lessons Learned from a Mobile Telehealth HCV Testing and Treatment Study. Viruses. 16(9). 1388–1388. 3 indexed citations

Stopka, Thomas J., Gillian Leichtling, Patrick F. Dowd, et al.. (2024). Barriers to opioid use disorder treatment among people who use drugs in the rural United States: A qualitative, multi-site study. Social Science & Medicine. 346. 116660–116660. 16 indexed citations

Whitney, Bridget M., Wiley D. Jenkins, Thomas J. Stopka, et al.. (2024). Behavioral and Health Outcome Differences by Heroin or Methamphetamine Preference Among People in Rural US Communities Who Use Both Substances. PubMed. 18. 3337205814–3337205814.

10.

Pivovarova, Ekaterina, et al.. (2024). Collaborating With Jails to Provide Community-based Medication for Opioid Use Disorder: Qualitative Perspectives From MOUD Treatment Providers. Journal of Addiction Medicine. 19(1). 95–101.

11.

Shrestha, Shikhar, et al.. (2024). Exploring Xylazine Awareness, Health Impacts, and Harm Reduction Strategies: Findings From a Multimethods Study in Lowell, Massachusetts. PubMed. 46(2). 291–301. 8 indexed citations

12.

Stopka, Thomas J., et al.. (2024). Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study. Addiction Science & Clinical Practice. 19(1). 68–68. 3 indexed citations

13.

Miller, William C., David Kline, Bridget M. Whitney, et al.. (2023). Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities. International Journal of Drug Policy. 141. 104222–104222. 4 indexed citations

14.

Bauer, Cici, Kehe Zhang, Wenjun Li, et al.. (2023). Small Area Forecasting of Opioid-Related Mortality: Bayesian Spatiotemporal Dynamic Modeling Approach. JMIR Public Health and Surveillance. 9. e41450–e41450. 7 indexed citations

15.

Stopka, Thomas J., et al.. (2022). Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers. International Journal of Drug Policy. 110. 103803–103803. 28 indexed citations

16.

Green, Traci C., Thomas J. Stopka, Ziming Xuan, et al.. (2021). Examining nonprescription syringe sales in Massachusetts and Rhode Island community pharmacies. Journal of the American Pharmacists Association. 61(4). e237–e241. 7 indexed citations

17.

Stopka, Thomas J., Lauren Brinkley‐Rubinstein, Kendra Johnson, et al.. (2018). HIV Clustering in Mississippi: Spatial Epidemiological Study to Inform Implementation Science in the Deep South. JMIR Public Health and Surveillance. 4(2). e35–e35. 19 indexed citations

18.

Ojikutu, Bisola O., Laura M. Bogart, Kenneth H. Mayer, et al.. (2018). Spatial Access and Willingness to Use Pre-Exposure Prophylaxis Among Black/African American Individuals in the United States: Cross-Sectional Survey. JMIR Public Health and Surveillance. 5(1). e12405–e12405. 42 indexed citations

19.

Nunn, Amy, Lauren Brinkley‐Rubinstein, Jennifer Rose, et al.. (2017). Latent class analysis of acceptability and willingness to pay for self‐HIV testing in a United States urban neighbourhood with high rates of HIV infection. Journal of the International AIDS Society. 20(1). 21290–21290. 24 indexed citations

20.

Singer, Merrill, Thomas J. Stopka, Kimberly Springer, et al.. (2000). The social geography of AIDS and hepatitis risk: qualitative approaches for assessing local differences in sterile-syringe access among injection drug users. American Journal of Public Health. 90(7). 1049–1056. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact